Bookmark Saya

CrossRef Open Access 2023 421 sitasi

Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial

Rohit Loomba Manal F Abdelmalek Matthew J Armstrong Maximilian Jara Mette Skalshøi Kjær +6 lainnya
Lihat Sumber DOI

Penulis (11)

R

Rohit Loomba

M

Manal F Abdelmalek

M

Matthew J Armstrong

M

Maximilian Jara

M

Mette Skalshøi Kjær

N

Niels Krarup

E

Eric Lawitz

V

Vlad Ratziu

A

Arun J Sanyal

J

Jörn M Schattenberg

P

Philip N Newsome

Format Sitasi

APA MLA BibTeX
Loomba, R., Abdelmalek, M.F., Armstrong, M.J., Jara, M., Kjær, M.S., Krarup, N. et al. (2023). Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial. https://doi.org/10.1016/s2468-1253(23)00068-7

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →
Lihat di Sumber doi.org/10.1016/s2468-1253(23)00068-7
Informasi Jurnal
Tahun Terbit
2023
Bahasa
en
Total Sitasi
421×
Sumber Database
CrossRef
DOI
10.1016/s2468-1253(23)00068-7
Akses
Open Access ✓